tiprankstipranks
Trending News
More News >
Lexaria Bioscience (LEXX)
NASDAQ:LEXX
US Market

Lexaria Bioscience (LEXX) Income Statement

Compare
236 Followers

Lexaria Bioscience Income Statement

Last quarter (Q3 2025), Lexaria Bioscience's total revenue was $174.00K, an increase of 107.14% from the same quarter last year. In Q3, Lexaria Bioscience's net income was $-3.79M. See Lexaria Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 25Dec 24Dec 23Dec 22
Total Revenue
$ 705.92K$ ―$ 464.28K$ 226.21K$ 255.40K
Gross Profit
$ 703.20K$ ―$ 459.46K$ 194.71K$ 183.56K
Operating Expenses
$ 12.58M$ ―$ 6.21M$ 6.73M$ 7.57M
Depreciation and Amortization
$ 0.00$ ―$ 76.15K$ 145.40K$ 102.72K
EBITDA
$ -11.88M$ ―$ -5.68M$ -6.39M$ -6.52M
Operating Income
$ -11.88M$ ―$ -5.75M$ -6.53M$ -6.62M
Other Income/Expenses
$ -21.10K$ ―$ -55.52K$ -178.50K$ -764.61K
Pretax Income
$ -11.90M$ ―$ -5.81M$ -6.71M$ -7.38M
Net Income
$ -11.90M$ ―$ -5.80M$ -6.66M$ -7.27M
Per Share Metrics
Basic EPS
$ -0.66$ ―$ -0.47$ -1.01$ -1.24
Diluted EPS
$ -0.66$ ―$ -0.47$ -1.01$ -1.24
Weighted Average Shares Outstanding
18.00M 12.38M 6.61M 5.89M
Weighted Average Shares Outstanding (Diluted)
18.00M 12.38M 6.61M 5.89M
Currency in USD

Lexaria Bioscience Earnings and Revenue History